Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Lexicon Pharmaceuticals, Inc.    LXRX   US5288721047

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2015 4,46 M
EBIT 2015 -118 M
Net income 2015 -128 M
Debt 2015 -
Yield 2015 -
Sales 2016 18,4 M
EBIT 2016 -145 M
Net income 2016 -164 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 178x
Capi. / Sales 2016 43,2x
Capitalization 796 M
More Financials
Company
Lexicon Pharmaceuticals, Inc. engages in discovery and development of breakthrough treatments for human disease.The company primarily focuses on the discovery of the functions and pharmaceutical utility of genes and the use of those gene function discoveries in the discovery and development of... 
Sector
Biotechnology & Medical Research
Calendar
06/06 | 09:00amPresentation
More about the company
Surperformance© ratings of Lexicon Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Latest news on LEXICON PHARMACEUTICALS, I
05/21 LEXICON PHARMACEUTICALS, INC. : REVERSE SPLIT: 1 of 7
05/15 LEXICON PHARMACEUTICALS : to Present at the Bank of America Merrill Lynch 2015 H..
05/12 LEXICON PHARMACEUTICALS : Announces Selection of Manuscript to be Presented at t..
05/07 LEXICON PHARMACEUTICALS : to Present at the Bank of America Merrill Lynch 2015 H..
05/06 LEXICON PHARMACEUTICALS : Announces One For Seven Reverse Stock Split Effective ..
05/05 LEXICON PHARMACEUTICALS : Management's Discussion and Analysis of Financial Cond..
04/29 LEXICON PHARMACEUTICALS : reports 1Q loss
04/29 LEXICON PHARMACEUTICALS : Results of Operations and Financial Condition, Other E..
More news
Sector news : Bio Therapeutic Drugs
08:08a ALNYLAM PHARMACEUTICALS : Initiates Phase 1 Clinical Trial for ALN-AS1, an Inves..
08:04a QUINTILES TRANSNATIONAL : CEO to Present at William Blair 35th Annual Growth Sto..
05/24 QUINTILES TRANSNATIONAL : Launches New Solution to Meet Needs of Asia-Pacific Em..
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
05/01 SEEKING ALPHA'S BIOTECH WEEKLY : A Gilead Victory, Celladon Crumbles, And More
05/01 Lexicon Undervalued As It Approaches A Major Event
04/29 Lexicon Pharmaceuticals' (LXRX) CEO Lonnel Coats on Q1 2015 Results - Earning..
04/29 Lexicon Pharmaceuticals EPS in-line, beats on revenue
03/20 Lexicon Pharmaceuticals - A Diamond In The Rough?
Comments 
Advertisement
Chart LEXICON PHARMACEUTICALS, I
Duration : Period :
Lexicon Pharmaceuticals, I Technical Analysis Chart | LXRX | US5288721047 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions